In a National Institutes of Health (NIH)-funded study, researchers developed a cancer assessment tool that can identify high-risk patients and the tumor cells linked to that risk.

Oregon Health & Science University researchers have developed a first-of-its-kind method to predict cancer patient survival ...

As recognized leaders in cancer research, Huntsman Cancer Institute physicians and scientists are utilizing artificial intelligence (AI) to accelerate discoveries and improve patient care. When I was ...

COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts Organ preservation has become an attractive alternative to ...

AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed.

Zongertinib in phase I trial showed sustained efficacy in aggressive disease ...

The firm stated that the stock is deeply undervalued, with a discounted cash flow estimate of around $30 per share. ・Investors are awaiting extended phase 3 data for CAN-2409 in prostate cancer, as ...

“1 in 20 Iowans have had a diagnosis of cancer in their lifetime, and if the trends continue, we’re headed towards one in 10.” Dr. Mary Charlton, Director of the Iowa Cancer Registry SIOUX CITY (KTIV) ...

Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. This voice experience is generated by AI. Learn more. This voice ...